Back
Gen Digital Vs. Novo Nordisk AS Industry Stock Comparison
Buy
65
GEN
Gen Digital
Last Price:
$27.51
Seasonality Move:
5.34%
Sell
25
NVO
Novo Nordisk AS
Last Price:
$87.66
Seasonality Move:
6.4%
Buy
65
Gen Digital (GEN)
is a Buy
Is Gen Digital a Buy, Sell or Hold?
-
The current Gen Digital [GEN] share price is $27.48. The Score for GEN is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
-
GEN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Novo Nordisk AS (NVO)
is a Sell
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NVO] share price is $87.52. The Score for NVO is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GEN Stock Price Chart
What is Gen Digital's stock price today?
-
The Gen Digital share price today is $27.48Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GEN is experiencing slight selling pressure.
NVO Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $87.52Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing selling pressure, which indicates risk of future bearish movement.
GEN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.63 | Sell |
Relative Strength Index (14 RSI): | 33.21 | Sell |
Chaikin Money Flow: | -889728 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (27.86 - 30.86) | Sell |
Bollinger Bands (100): | (26.05 - 29.57) | Sell |
NVO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.1 | Sell |
Relative Strength Index (14 RSI): | 29.77 | Sell |
Chaikin Money Flow: | -2256076 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (91.29 - 111.41) | Sell |
Bollinger Bands (100): | (102.22 - 130.72) | Sell |
GEN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 27.64 | Sell |
20-day SMA: | 28.98 | Sell |
50-day SMA: | 29.1 | Sell |
200-day SMA: | 25.64 | Buy |
8-day EMA: | 27.75 | Sell |
20-day EMA: | 28.51 | Sell |
50-day EMA: | 28.69 | Sell |
200-day EMA: | 26.18 | Buy |
NVO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 86.92 | Buy |
20-day SMA: | 99.85 | Sell |
50-day SMA: | 104.9 | Sell |
200-day SMA: | 124.64 | Sell |
8-day EMA: | 89.57 | Sell |
20-day EMA: | 96.24 | Sell |
50-day EMA: | 104.44 | Sell |
200-day EMA: | 116 | Sell |
Gen Digital Earnings Growth & GEN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.25 per share.
Novo Nordisk AS Earnings Growth & NVO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $0.66 per share.
Gen Digital Technical Analysis
Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
18 | 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |